ClinicalTrials.Veeva

Menu

Comparison of ARISCAT Score and Post-operative Pulmonary Complication Rate in Percutaneous Nephrolithotomy

S

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Status

Completed

Conditions

Postoperative Complications
Nephrolithotomy, Percutaneous

Study type

Observational

Funder types

Other

Identifiers

NCT06415253
MAIEAH630003

Details and patient eligibility

About

Postoperative pulmonary complications are relatively common in all age groups and are closely related to increased costs, morbidity and mortality in the postoperative period. In recent years, various risk indices have been developed for preoperative evaluation to predict postoperative pulmonary complications, such as the American Society of Anaesthesiologists Physical Status Classification (ASA), the Assessment of Respiratory Risk in Surgical Patients in Catalonia (ARISCAT). The ARISCAT score has demonstrated promising results in identifying patients at higher risk for pulmonary complications. The ARISCAT risk index is derived from multiple variables, including age, oxygen saturation, previous respiratory tract infections, anaemia, abdominal or thoracic surgery, operative time, and emergency surgery. The ARISCAT risk index is used to predict respiratory failure, bronchospasm, respiratory tract infections, atelectasis, pneumothorax, pleural effusion, and aspiration pneumonia.

Percutaneous nephrolithotomy (PNL) is a type of operation performed endoscopically in a prone position in cases of kidney stones that cannot be broken by extracorporeal shockwave lithotripsy (ESWL) and/or cannot be removed by ureterocystoscopy. The prone position is one of the positions that limits lung capacity and respiratory function. The objective of this study was to assess the relationship between the ARISCAT score in patients undergoing PNL and the occurrence of pulmonary complications in the postoperative period.

Enrollment

50 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) I-III patients
  • Patients who undergone of Percutaneous Nephrolithotomy procedure

Exclusion criteria

  • Patients with any liver and/or kidney failure
  • Obese patients (body mass index (BMI) 30 and above)
  • Trauma patients
  • Cancer patients
  • American Society of Anesthesiologists (ASA) IV patients
  • Cardiac arrhythmia, implanted pacemakers
  • A history of chronic pain

Trial design

50 participants in 1 patient group

Patients who had undergone Percutaneous Nephrolithotomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems